March 30, 2022, Ottawa – Canadian Blood Services’ contracts with suppliers of recombinant factor VIII and IX for the 2022-2025 period take effect on April...
Montreal, December 16, 2021 – The rollout of emicizumab (Hemlibra) in the provinces and territories served by Canadian Blood Services (CBS) is well underway. Emicizumab...
November 10, 2021 (Montreal) – The Hemlibra rollout continues in provinces served by Canadian Blood Services (CBS). Since access requests from physicians began to be...
October 20, 2021, Montreal – Children 12 years of age and under can now access extended half-life (EHL) factor IX in Quebec for the prophylactic...
Montreal, September 13, 2021 – In recent weeks, governments in both Quebec and the rest of Canada have expanded access to Hemlibra to patients with...
